To explore whether depletion of mutant IDH sensitizes chondrosarcoma cells to compounds from our drug screening library, we performed a drug sensitivity analysis in mutant IDH1 KO clones (J14 and H2), comparing their responses with those of the parental cells. The gene discussed is IDH2; the disease is chondrosarcoma.